First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer
在一项大型真实世界非小细胞肺癌患者队列研究中,第一代或第二代表皮生长因子受体酪氨酸激酶抑制剂的疗效
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359211035710
Huang, Allen Chung-Cheng; Huang, Chi-Hsien; Ju, Jia-Shiuan; Chiu, Tzu-Hsuan; Tung, Pi-Hung; Wang, Chin-Chou; Liu, Chien-Ying; Chung, Fu-Tsai; Fang, Yueh-Fu; Guo, Yi-Ke; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta